4.6 Review

Pericardial fluid: an underrated molecular library of heart conditions and a potential vehicle for cardiac therapy

期刊

BASIC RESEARCH IN CARDIOLOGY
卷 114, 期 2, 页码 -

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-019-0716-3

关键词

Heart disease; Pericardial fluid; Systems medicine; Biomarker; Intrapericardial therapeutics

资金

  1. Portuguese Foundation for Science and Technology (FCT)
  2. European Union
  3. Quadro de Referencia Estrategico Nacional (QREN)
  4. Fundo Europeu de Desenvolvimento Regional (FEDER)
  5. Programa Operacional Fatores de Competitividade (COMPETE) [UID/BIM/04501/2013, POCI-01-0145-FEDER-007628, UID/IC/00051/2013]
  6. Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000003]
  7. European Structural and Investment Funds [POCI-01-0145-FEDER-016385]
  8. PFCT
  9. Lisbon's Regional Operational Programme 2020
  10. [IF/00286/2015]
  11. [SFRH/BD/111633/2015]
  12. Fundação para a Ciência e a Tecnologia [SFRH/BD/111633/2015] Funding Source: FCT

向作者/读者索取更多资源

The remote but heart-encircling location of pericardial fluid confers this biofluid unique properties. Once past the limitation of the invasive collection, for instance, on occasion of heart surgery or pericardiocentesis, the scrutiny of pericardial fluid content can be of great interest in cardiovascular research. This liquid concentrates many heart-derived factors, thus enclosing several surrogate markers for the diagnosis or prognosis of a large spectrum of diseases either pericardial (e.g. malignant or tuberculous pericarditis) or non-pericardial/heart diseases (e.g. coronary artery disease or valvular heart diseases). Herein, for the first time, the molecular knowledge of pericardial fluid is reviewed, through an in-depth literature search and mining, and then translated into a network map of the diseases influencing pericardial fluid composition. The suitability of pericardial fluid for biomarker research could be demonstrated by evident molecular profiles between different conditions as well as by stronger correlations to cardiac structural and functional parameters, fainter or lacking in plasma/serum. Also highlighted here are the results of mechanistic research conducted with pericardial fluid in several hot topics of research, such as chronotropy, inotropy, coronary perfusion and cardiac electrophysiology. Moreover, the progress in intrapericardial therapeutics, motivated by pericardial fluid's low clearance rates, higher efficiency and lesser risk of systemic effects over conventional delivery methods, is surveyed and discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据